- Report ID: BMRC 287 | Number of pages: 200 | Publish Date: Dec 2019
Status: Published | Category: Healthcare | Delivery Timeline:
Microfluidics Market Increasing prevalence of chronic diseases like HIV, cancer, diabetes, cardiovascular diseases, brain disorders and technological advancement are key drivers responsible for the growth of Microfluidics Market.
It is the science of manipulating and controlling fluids, usually in the range of microliters (10-6) to picoliters (10-12), in networks of channels with dimensions from tens to hundre0ds of micrometers. So during the study of global Microfluidics market, we have considered Microfluidics devices and consumables to analyze the market.
Global Microfluidics market report is segmented on the basis of product type, application, material, end user & geography. Based upon Product type it is classified as Microfluidics chip, instrument, cartridges and reagent. Based upon application it is classified as Peripheral vascular diseases, wound care management, Pharmaceutical and Biotech Research, In-vitro Diagnostics Drug delivery. On the basis of material it is classified as Silicon based, Glass based, Polymer based. On the basis of end users it is classified as Hospitals, Academics, Research Institute, Diagnostic Labs, and Homecare setting.
The regions covered in this Global Microfluidics market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Computed Tomography is sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Danaher Corporation, PerkinElmer,Inc.,Agilent Technologies, Inc., Bio-Rad Laboratories, Inc, Thermo Fisher Scientific Inc, RainDance Technologies, Inc., Hoffmann La-Roche Ltd.
The rising healthcare condition is the key driving factors for the growth of the micro fluidics market for earlier detection of infectious diseases such as HIV, cancer, diabetes, cardiovascular diseases, brain disorders and sleep disorders and AIDS, easier monitoring and increased personalization, to reaching under-served and remote populations. Moreover, increasing investment in research & development from medical device manufacturers are continuously responsible for the growth of global Microfluidics market. However, Market is highly regulated with stringent and time-consuming approval processes and high cost of instrument are expected to inhibit the growth of the Microfluidics market. Microfluidics chips are sold in market with cost between USD 500 to 5000. Nonetheless, untapped market and technology advancement may generate new opportunities in forecast period.
By Product Type
By End User
Interested in this report?
Microfluidics Market By Product Type (Microfluidics Chip, Cartridges & Reagent), By Application (Peripheral Vascular Diseases, Wound Care Management, In vitro Diagnostics, Drug Delivery), By Material (Silicon-Based Microfluidicss, Glass-Based Microfluidicss, Polymer-Based Microfluidicss), Industry Analysis, Trends, and Forecast 2019